Remove 2004 Remove Licensing Remove World Health
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

This proposal builds upon the existing legal framework, which came into force in 2002 for blood and 2004 for tissues and cells. It also fosters innovation in this crucial biotech sector. The framework contains parallel provisions for donor selection, quality and safety management and oversight.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – July and August 2023

SQA

World Health Organization (WHO) Medical Product Alert N o 5/2023: Substandard (Contaminated) Syrup Medicines, 19 July 2023 Medical Product Alert N o 5/2023 refers to a batch of substandard (contaminated) Naturcold Syrup identified in Cameroon and first reported to WHO on 13 March 2023.

FDA 40